Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunity

Arthritis Research and Therapy

Volumn 10, Issue 5, 2008, Pages

  Wither, Joan ^a,b   Cai, Yong Chun ^b   Lim, Sooyeol ^c   McKenzie, Tamara ^b   Roslin, Nicole ^c   Claudio, Jaime O ^b   Cooper, Glinda S ^d   Hudson, Thomas J ^e,f   Paterson, Andrew D ^c   Greenwood, Celia M T ^c   Gladman, Dafna ^a,g   Pope, Janet ^h   Pineau, Christian A ⁱ   Smith, C Douglas ^j   Hanly, John G ^k   Peschken, Christine ^l   Boire, Gilles ^m   Urowitz, Murray ^g   Bernatsky, Sasha ⁿ   Clarke, Ann ⁿ   Rich , Eric ^o   Hitchon, Carol ^p   Carette, Simon ^b   Inman, Robert ^b   Albert, Lori ^b   Barr, Susan ^q   Fortin, Paul R ^a,b,g   more..

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

^c HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^e MCGILL UNIVERSITY   (Canada)

^f ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h ST JOSEPH S HEALTH CENTRE   (Canada)

ⁱ MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^j UNIVERSITY OF OTTAWA   (Canada)

^k DALHOUSIE UNIVERSITY   (Canada)

^l UNIVERSITY OF MANITOBA   (Canada)

^m UNIVERSITÉ DE SHERBROOKE   (Canada)

ⁿ MONTREAL GENERAL HOSPITAL   (Canada)

^o NOTRE DAME HOSPITAL   (Canada)

^p HEALTH SCIENCES CENTRE   (Canada)

^q UNIVERSITY OF CALGARY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; LEUKOCYTE ANTIGEN;

ADULT; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FLOW CYTOMETRY; HEREDITY; HUMAN; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; MEMORY T LYMPHOCYTE; NATURAL KILLER T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; RELATIVE; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; FAMILY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METABOLISM; PEDIGREE;

ADULT; ANTIBODIES, ANTINUCLEAR; ANTIGENS, CD; AUTOIMMUNITY; FAMILY; FEMALE; FLOW CYTOMETRY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; NATURAL KILLER T-CELLS; PEDIGREE; PHENOTYPE;

EID: 53649099968     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2505     Document Type: Article

References (60)

1. Vyse TJ Kotzin BL Genetic susceptibility to systemic lupus erythematosus Annu Rev Immunol 1998, 16:261-292. 9597131
2. Wakeland EK Liu K Graham RR Behrens TW Delineating the genetic basis of systemic lupus erythematosus Immunity 2001, 15:397-408. 11567630
3. Sestak AL Nath SK Harley JB Genetics of systemic lupus erythematosus: how far have we come? Rheum Dis Clin North Am 2005, 31:223-244. 15922143
4. Harley JB arcon-Riquelme ME Criswell LA Jacob CO Kimberly RP Moser KL Tsao BP Vyse TJ Langefeld CD Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci Nat Genet 2008, 40:204-210. 18204446
5. Hom G Graham RR Modrek B Taylor KE Ortmann W Garnier S Lee AT Chung SA Ferreira RC Pant PV Ballinger DG Kosoy R Demirci FY Kamboh MI Kao AH Tian C Gunnarsson I Bengtsson AA Rantapaa-Dahlqvist S Petri M Manzi S Seldin MF Ronnblom L Syvanen AC Criswell LA Gregersen PK Behrens TW Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX N Engl J Med 2008, 358:900-909. 18204098
6. Fairhurst AM Wandstrat AE Wakeland EK Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease Adv Immunol 2006, 92:1-69. 17145301
7. Henry T Mohan C Systemic lupus erythematosus: Recent clues from congenic strains Arch Immunol Ther Exp (Warsz) 2005, 53:207-212. 15995581
8. Wither JE Lajoie G Heinrichs S Cai YC Chang N Ciofani A Cheung YH MacLeod R Functional dissection of lupus susceptibility loci on the New Zealand black mouse chromosome 1: Evidence for independent genetic loci affecting T and B cell activation J Immunol 2003, 171:1697-1706. 12902468
9. Wither JE Loh C Lajoie G Heinrichs S Cai YC Bonventi G MacLeod R Colocalization of expansion of the splenic marginal zone population with abnormal B cell activation and autoantibody production in B6 mice with an introgressed New Zealand Black chromosome 13 interval J Immunol 2005, 175:4309-4319. 16177071
10. Laustrup H Heegaard NH Voss A Green A Lillevang ST Junker P Autoantibodies and self-reported health complaints in relatives of systemic lupus erythematosus patients: A community based approach Lupus 2004, 13:792-799. 15540512
11. Miles S Isenberg D A review of serological abnormalities in relatives of SLE patients Lupus 1993, 2:145-150. 8369805
12. Namjou B Nath SK Kilpatrick J Kelly JA Reid J Reichlin M James JA Harley JB Genome scan stratified by the presence of anti-double-stranded DNA (dsDNA) autoantibody inpedigrees: Multiplex for systemic lupus erythematosus (SLE) establishes linkages at 19p13.2 (SLED1) and 18q21.1 (SLED2) Genes Immun 2002, 3(suppl 1):S35-S41. 12215900
13. Ramos PS Kelly JA Gray-McGuire C Bruner GR Leiran AN Meyer CM Namjou B Espe KJ Ortmann WA Reichlin M Langefeld CD James JA Gaffney PM Behrens TW Harley JB Moser KL Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus Genes Immun 2006, 7:417-432. 16775618
14. Bourne T Zukowska-Cooper M Salaman MR Seifert MH Isenberg DA Spontaneous immunoglobulin-producing capacity of cultures from lupus patients and normal donors following depletion of cells expressing CD19 or CD38 Clin Exp Immunol 1998, 111:611-616. 1904880 9528907
15. Sakane T Suzuki N Takada S Ueda Y Murakawa Y Tsuchida T Yamauchi Y Kishimoto T B cell hyperactivity and its relation to distinct clinical features and the degree of disease activity in patients with systemic lupus erythematosus Arthritis Rheum 1988, 31:80-87. 3257876
16. Folzenlogen D Hofer MF Leung DY Freed JH Newell MK Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients Clin Immunol Immunopathol 1997, 83:199-204. 9175908
17. Spronk PE Horst G Gun Van Der BT Limburg PC Kallenberg CG Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE) Clin Exp Immunol 1996, 104:446-453. 2200455 9099929
18. Viallard JF Bloch-Michel C Neau-Cransac M Taupin JL Garrigue S Miossec V Mercie P Pellegrin JL Moreau JF HLA-DR expression on lymphocyte subsets as a marker of disease activity in patients with systemic lupus erythematosus Clin Exp Immunol 2001, 125:485-491. 1906149 11531958
19. Bijl M Horst G Limburg PC Kallenberg CG Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus Ann Rheum Dis 2001, 60:523-526. 1753642 11302879
20. Su CC Shau WY Wang CR Chuang CY Chen CY CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activity Lupus 1997, 6:449-454. 9229364
21. Chang NH McKenzie T Bonventi G Landolt-Marticorena C Fortin PR Gladman D Urowitz M Wither JE Expanded population of activated antigen-engaged cells within the naive B cell compartment of patients with systemic lupus erythematosus J Immunol 2008, 180:1276-1284. 18178868
22. Anolik JH Barnard J Cappione A Pugh-Bernard AE Felgar RE Looney RJ Sanz I Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus Arthritis Rheum 2004, 50:3580-3590. 15529346
23. Arce E Jackson DG Gill MA Bennett LB Banchereau J Pascual V Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus J Immunol 2001, 167:2361-2369. 11490026
24. + double-negative regulatory natural killer T cells in autoimmune diseases Arthritis Rheum 2001, 44:1127-1138. 11352245
25. Oishi Y Sumida T Sakamoto A Kita Y Kurasawa K Nawata Y Takabayashi K Takahashi H Yoshida S Taniguchi M Saito Y Iwamoto I Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus J Rheumatol 2001, 28:275-283. 11246661
26. Kang HK Datta SK Regulatory T cells in lupus Int Rev Immunol 2006, 25:5-25. 16531276
27. Mellor-Pita S Citores MJ Castejon R Tutor-Ureta P Yebra-Bango M Andreu JL Vargas JA Decrease of regulatory T cells in patients with systemic lupus erythematosus Ann Rheum Dis 2006, 65:553-554. 16531555
28. Miyara M Amoura Z Parizot C Badoual C Dorgham K Trad S Nochy D Debre P Piette JC Gorochov G Global natural regulatory T cell depletion in active systemic lupus erythematosus J Immunol 2005, 175:8392-8400. 16339581
29. van Elteren PH On the combination of independent two-sample tests of Wilcoxon Bull Int Stat Inst 1960, 37:351-361.
30. Hammond KJ Godfrey DI NKT cells: Potential targets for autoimmune disease therapy? Tissue Antigens 2002, 59:353-363. 12144618
31. Linsen L Somers V Stinissen P Immunoregulation of autoimmunity by natural killer T cells Hum Immunol 2005, 66:1193-1202. 16690406
32. Yu KO Porcelli SA The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy Immunol Lett 2005, 100:42-55. 16083968
33. Kukreja A Cost G Marker J Zhang C Sun Z Lin-Su K Ten S Sanz M Exley M Wilson B Porcelli S Maclaren N Multiple immuno-regulatory defects in type-1 diabetes J Clin Invest 2002, 109:131-140. 150819 11781358
34. Jacobson DL Gange SJ Rose NR Graham NM Epidemiology and estimated population burden of selected autoimmune diseases in the United States Clin Immunol Immunopathol 1997, 84:223-243. 9281381
35. Clark J Bourne T Salaman MR Seifert MH Isenberg DA B lymphocyte hyperactivity in families of patients with systemic lupus erythematosus J Autoimmun 1996, 9:59-65. 8845055
36. Green MR Kennell AS Larche MJ Seifert MH Isenberg DA Salaman MR Natural killer cell activity in families of patients with systemic lupus erythematosus: Demonstration of a killing defect in patients Clin Exp Immunol 2005, 141:165-173. 1809425 15958083
37. Green MR Kennell AS Larche MJ Seifert MH Isenberg DA Salaman MR Natural killer T cells in families of patients with systemic lupus erythematosus: Their possible role in regulation of IGG production Arthritis Rheum 2007, 56:303-310. 17195234
38. Montoya CJ Pollard D Martinson J Kumari K Wasserfall C Mulder CB Rugeles MT Atkinson MA Landay AL Wilson SB Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11 Immunology 2007, 122:1-14. 2265989 17662044
39. Graham DS Vyse TJ Fortin PR Montpetit A Cai YC Lim S McKenzie T Farwell L Rhodes B Chad L Hudson TJ Sharpe A Terhorst C Greenwood CM Wither J Rioux JD Association of LY9 in UK and Canadian SLE families Genes Immun 2008, 9:93-102. 18216865
40. van d V von Blomberg BM Nishi N Reijm M Voskuyl AE van Bodegraven AA Polman CH Rustemeyer T Lips P Eertwegh van den AJ Giaccone G Scheper RJ Pinedo HM Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage Clin Immunol 2001, 100:144-148. 11465942
41. Sumida T Sakamoto A Murata H Makino Y Takahashi H Yoshida S Nishioka K Iwamoto I Taniguchi M Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis J Exp Med 1995, 182:1163-1168. 2192293 7561690
42. Yanagihara Y Shiozawa K Takai M Kyogoku M Shiozawa S Natural killer (NK) T cells are significantly decreased in the peripheral blood of patients with rheumatoid arthritis (RA) Clin Exp Immunol 1999, 118:131-136. 1905408 10540170
43. + NKT cells derived from multiple sclerosis in remission Int Immunol 2003, 15:279-288. 12578858
44. Wilson SB Kent SC Patton KT Orban T Jackson RA Exley M Porcelli S Schatz DA Atkinson MA Balk SP Strominger JL Hafler DA Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes Nature 1998, 391:177-181. 9428763
45. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10 J Exp Med 1998, 187:1047-1056. 2212199 9529321
46. Sharif S Arreaza GA Zucker P Mi QS Sondhi J Naidenko OV Kronenberg M Koezuka Y Delovitch TL Gombert JM Leite-De-Moraes M Gouarin C Zhu R Hameg A Nakayama T Taniguchi M Lepault F Lehuen A Bach JF Herbelin A Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes Nat Med 2001, 7:1057-1062. 11533711
47. Shi FD Flodstrom M Balasa B Kim SH Van GK Strominger JL Wilson SB Sarvetnick N Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse Proc Natl Acad Sci USA 2001, 98:6777-6782. 34429 11390999
48. Wang B Geng YB Wang CR CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes J Exp Med 2001, 194:313-320. 2193465 11489950
49. Singh AK Wilson MT Hong S Olivares-Villagomez D Du C Stanic AK Joyce S Sriram S Koezuka Y Van KL Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis J Exp Med 2001, 194:1801-1811. 2193577 11748281
50. + T cells that promptly produce interleukin 4 Proc Natl Acad Sci USA 1995, 92:11931-11934. 40517 8524877
51. Chiba A Oki S Miyamoto K Hashimoto H Yamamura T Miyake S Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide Arthritis Rheum 2004, 50:305-313. 14730629
52. + NK T cells associated with disease development in autoimmune-prone mice J Immunol 1996, 156:4035-4040. 8621946
53. Yang JQ Saxena V Xu H Van KL Wang CR Singh RR Repeated alpha-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice J Immunol 2003, 171:4439-4446. 14530371
54. Forestier C Molano A Im JS Dutronc Y Diamond B Davidson A Illarionov PA Besra GS Porcelli SA Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black × New Zealand White)F1 mice J Immunol 2005, 175:763-770. 16002672
55. Zeng D Lee MK Tung J Brendolan A Strober S Cutting edge: A role for CD1 in the pathogenesis of lupus in NZB/NZW mice J Immunol 2000, 164:5000-5004. 10799851
56. Zeng D Liu Y Sidobre S Kronenberg M Strober S Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus J Clin Invest 2003, 112:1211-1222. 213484 14561706
57. Singh AK Yang JQ Parekh VV Wei J Wang CR Joyce S Singh RR Van KL The natural killer T cell ligand alpha-galactosylceramide prevents or promotes pristane-induced lupus in mice Eur J Immunol 2005, 35:1143-1154. 2291523 15761849
58. Chiba A Kaieda S Oki S Yamamura T Miyake S The involvement of V(alpha)14 natural killer T cells in the pathogenesis of arthritis in murine models Arthritis Rheum 2005, 52:1941-1948. 15934073
59. Jahng AW Maricic I Pedersen B Burdin N Naidenko O Kronenberg M Koezuka Y Kumar V Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis J Exp Med 2001, 194:1789-1799. 2193586 11748280
60. Miyamoto K Miyake S Yamamura T A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells Nature 2001, 413:531-534. 11586362